Back
Halozyme Therapeutics Vs. BioLife Solutions Industry Stock Comparison
Buy
69
HALO
Halozyme Therapeutics
Last Price:
53.92
Seasonality Move:
17.03%
Buy
58
BLFS
BioLife Solutions
Last Price:
21.82
Seasonality Move:
6.14%
Buy
69
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $58.61. The Score for HALO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
BioLife Solutions (BLFS)
is a Buy
Is BioLife Solutions a Buy, Sell or Hold?
- The current BioLife Solutions [BLFS] share price is $24.11. The Score for BLFS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BLFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $58.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.
BLFS Stock Price Chart
What is BioLife Solutions's stock price today?
-
The BioLife Solutions share price today is $24.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLFS is experiencing selling pressure, which indicates risk of future bearish movement.
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.38 | Buy |
| Relative Strength Index (14 RSI): | 57.76 | Buy |
| Chaikin Money Flow: | -684125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 58.42) | Buy |
| Bollinger Bands (100): | (52.31 - 60.31) | Buy |
BLFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.61 | Buy |
| Relative Strength Index (14 RSI): | 47.51 | Sell |
| Chaikin Money Flow: | -948223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.36 - 25.5) | Buy |
| Bollinger Bands (100): | (21.8 - 25.46) | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.73 | Sell |
| 20-day SMA: | 54.8 | Buy |
| 50-day SMA: | 56.65 | Buy |
| 200-day SMA: | 48.77 | Buy |
| 8-day EMA: | 58.73 | Sell |
| 20-day EMA: | 56.7 | Buy |
| 50-day EMA: | 56.13 | Buy |
| 200-day EMA: | 50.75 | Buy |
BLFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.95 | Sell |
| 20-day SMA: | 24.18 | Sell |
| 50-day SMA: | 24.11 | Sell |
| 200-day SMA: | 21.14 | Buy |
| 8-day EMA: | 25.44 | Sell |
| 20-day EMA: | 24.73 | Sell |
| 50-day EMA: | 24.19 | Sell |
| 200-day EMA: | 21.71 | Buy |
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.
BioLife Solutions Earnings Growth & BLFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $0.21 per share.
Halozyme Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioLife Solutions Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||